A specific lot of the widely prescribed anti-anxiety drug Xanax has been recalled nationwide for not passing quality control tests according to the Food and Drug Administration.
Kivo reports that quality control significantly drives up prescription costs by ensuring safety and compliance in the pharmaceutical industry.
The FDA issued a voluntary recall of Xanax XR manufactured by Viatris due to failure to meet dissolution specifications, ...
Quality control errors during pharmaceutical manufacturing are unfortunately common occurrences. The majority (around 50%) of employees that work in pharmaceutical manufacturing tend to have duties ...
In a fresh drug safety alert underscoring continued regulatory vigilance, 48 batches of drugs, medical devices, and allied ...